CoreFirst Bank & Trust Decreases Stock Holdings in Colgate-Palmolive (NYSE:CL)

CoreFirst Bank & Trust lowered its position in Colgate-Palmolive (NYSE:CL) by 0.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 132,039 shares of the company’s stock after selling 450 shares during the quarter. Colgate-Palmolive comprises approximately 7.0% of CoreFirst Bank & Trust’s portfolio, making the stock its 2nd largest holding. CoreFirst Bank & Trust’s holdings in Colgate-Palmolive were worth $10,525,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in CL. Vanguard Group Inc. increased its stake in Colgate-Palmolive by 0.5% in the fourth quarter. Vanguard Group Inc. now owns 79,894,344 shares of the company’s stock valued at $6,368,378,000 after acquiring an additional 416,853 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its position in Colgate-Palmolive by 16.8% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 32,133,218 shares of the company’s stock valued at $2,561,340,000 after buying an additional 4,625,472 shares during the period. Morgan Stanley boosted its position in Colgate-Palmolive by 3.2% during the third quarter. Morgan Stanley now owns 16,815,987 shares of the company’s stock valued at $1,195,785,000 after buying an additional 514,559 shares during the period. Northern Trust Corp boosted its position in Colgate-Palmolive by 3.3% during the third quarter. Northern Trust Corp now owns 9,452,931 shares of the company’s stock valued at $672,198,000 after buying an additional 305,862 shares during the period. Finally, Norges Bank purchased a new stake in shares of Colgate-Palmolive during the fourth quarter worth about $731,843,000. Institutional investors own 80.41% of the company’s stock.

Wall Street Analyst Weigh In

CL has been the subject of several research analyst reports. Stifel Nicolaus raised their price objective on shares of Colgate-Palmolive from $94.00 to $95.00 and gave the stock a “buy” rating in a report on Monday, April 29th. Citigroup raised their target price on shares of Colgate-Palmolive from $95.00 to $100.00 and gave the stock a “buy” rating in a report on Tuesday, April 16th. Bank of America lifted their price target on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the stock a “buy” rating in a research note on Monday, April 29th. The Goldman Sachs Group started coverage on shares of Colgate-Palmolive in a research note on Friday, March 1st. They set a “buy” rating and a $93.00 price target on the stock. Finally, StockNews.com downgraded shares of Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, February 20th. Three analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat, Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and a consensus target price of $92.94.

Colgate-Palmolive Stock Up 1.4 %

Shares of NYSE CL traded up $1.33 during trading hours on Monday, hitting $95.95. 3,445,394 shares of the stock were exchanged, compared to its average volume of 4,443,382. The company has a quick ratio of 0.70, a current ratio of 1.06 and a debt-to-equity ratio of 13.21. The company has a market cap of $78.72 billion, a PE ratio of 30.36, a PEG ratio of 3.48 and a beta of 0.39. The firm has a fifty day moving average price of $91.86 and a 200-day moving average price of $86.39. Colgate-Palmolive has a 12 month low of $67.62 and a 12 month high of $96.08.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, April 26th. The company reported $0.86 EPS for the quarter, topping the consensus estimate of $0.82 by $0.04. The firm had revenue of $5.07 billion during the quarter, compared to analyst estimates of $4.96 billion. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. Colgate-Palmolive’s revenue was up 6.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.73 EPS. On average, sell-side analysts expect that Colgate-Palmolive will post 3.53 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Friday, July 19th will be paid a dividend of $0.50 per share. The ex-dividend date is Friday, July 19th. This represents a $2.00 dividend on an annualized basis and a yield of 2.08%. Colgate-Palmolive’s payout ratio is 63.29%.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, insider John W. Kooyman sold 3,497 shares of the company’s stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total transaction of $326,864.59. Following the transaction, the insider now owns 3,181 shares in the company, valued at approximately $297,328.07. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, insider John W. Kooyman sold 3,497 shares of the company’s stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total value of $326,864.59. Following the sale, the insider now directly owns 3,181 shares of the company’s stock, valued at approximately $297,328.07. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Sally Massey sold 12,226 shares of the company’s stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the completion of the sale, the insider now directly owns 13,924 shares in the company, valued at $1,309,691.44. The disclosure for this sale can be found here. 0.37% of the stock is currently owned by company insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.